Clinical trial
Pediatric Hypothalamic Obesity
NCT00076362 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00076362 |
|---|---|
| Title | Pediatric Hypothalamic Obesity |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | Sandostatin LAR |
| Enrollment | 60 |
| Start date | Mar 1, 2004 |
| Primary completion | Jul 1, 2005 |
| First posted | Jan 23, 2004 |
| Last update posted | Sep 12, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: